Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase-or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?
ISSN
03057453
Date Issued
2020
Author(s)
DOI
10.1093/jac/dkz421